Skip to main content
SpringerLink
Log in

ICER posts draft document on voretigene neparvovec

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Comparative Effectiveness Public Advisory Council

Reference

  • Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Posts Draft Scoping Document on Voretigene Neparvovec, First Gene Therapy Submitted for FDA Approval. Internet Document : 10 Jul 2017. Available from: URL: https://icer-review.org/announcements/voretigene-draft-scope/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ICER posts draft document on voretigene neparvovec. PharmacoEcon Outcomes News 782, 2 (2017). https://doi.org/10.1007/s40274-017-4133-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4133-2

Search

Navigation